Announced
Completed
Synopsis
Danaher Corporation, Agilent Technologies, Life Sciences Partners, Casdin Capital, Illumina Ventures, Bpifrance and Merck Ventures invested $89m Series B funding round in DNA Script, a biotechnology company. “The SYNTAX EDS system was inspired by the wide availability of in-lab and benchtop next-generation sequencing systems and the impact they have had on genomics research and personalized medicine. This first-of-its-kind DNA printer makes writing DNA as simple and straightforward as reading DNA is currently, meaning that research and clinical labs will be able to do same-day synthesis of oligonucleotides, saving precious time when it comes to iterating experiments or developing diagnostic or confirmatory tools," Thomas Ybert, DNA Script CEO and Co-Founder.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.